Infection Control Today - Immune System

IQ Corporation’s Anthrax Products Selected for Testing by CDC

GRONINGEN, The Netherlands -- IQ Corporation (IQC), a Dutch biopharmaceutical company, today announced that its two anti-anthrax therapy products have been selected by the Centers for Disease Control and Prevention (CDC) for testing and evaluation by the government. ...More

June 24, 2004

Posted in News

CDC Collaboration Yields New Test for Anthrax

A new test funded by the Centers for Disease Control and Prevention (CDC) and developed in collaboration with a commercial partner has become the first test approved by the Food and Drug Administration (FDA) for detecting antibodies to anthrax. The test, produced by ...More

June 8, 2004

Posted in News

Left-Brain Damage May Make People More Vulnerable to Infection

A major immunological difference between the opposite halves of the human brain is now confirmed in a study published May 24, 2004 in the online edition of the Annals of Neurology. Researchers have found that damage or surgery to the left half of the brain may make a ...More

May 25, 2004

Posted in News

Second NIAID SARS Vaccine Candidate Helps Mice Fend Off SARS

An experimental vaccine based on a critical piece of the SARS virus protects mice from SARS infection, researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have found. When exposed to the SARS virus, ...More

April 20, 2004

Posted in News, PPE & Standard Precautions

NIAID Vaccine Protects Against SARS Virus Infection in Mice

An experimental vaccine prevents the SARS virus from replicating in laboratory mice, according to a new report in the April 1, 2004 issue of Nature. Scientists at the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), one of ...More

April 1, 2004

Posted in News, PPE & Standard Precautions

OraSure Receives FDA Approval for Test to Detect HIV-2 Antibodies

BETHLEHEM, Pa. -- OraSure Technologies, Inc. announces that the U.S. Food and Drug Administration (FDA) has approved the company's new OraQuick Rapid HIV-1/2 Antibody Test. This approval will allow the simultaneous detection of antibodies to both the HIV-1 and HIV-2 viruses ...More

March 26, 2004

Posted in News

Beckman Coulter Signs Exclusive Deal for New Sepsis Marker

FULLERTON, Calif. -- Beckman Coulter, Inc. announces it has signed an exclusive licensing agreement with Research and Diagnostic Antibodies LLC for R&D Abs' inducible nitric oxide (iNOS) monoclonal antibodies and patents. iNOS is an exciting new marker in blood that ...More

March 19, 2004

Posted in News

Mouse Antibodies Thwart SARS Virus

WASHINGTON -- The mouse immune system develops antibodies capable of single-handedly neutralizing the SARS virus, researchers at the National Institute of Allergy and Infectious Diseases (NIAID) report in the April 1 issue of the Journal of Virology. NIAID is part of the ...More

March 16, 2004

Posted in News, PPE & Standard Precautions

Viragen Files U.S. Patent Application for Natural Interferon to Target SARS

PLANTATION, Fla. -- Viragen, Inc. today announced that it has filed a patent application in the United States covering the use of its natural human leukocyte-derived alpha interferon for the treatment and prevention of severe acute respiratory syndrome (SARS). This is ...More

March 10, 2004

Posted in News, PPE & Standard Precautions

Nabi Biopharmaceuticals Receives FDA Orphan Drug Designation for Altastaph

BOCA RATON, Fla. - Nabi Biopharmaceuticals announces that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Nabi's investigational product, Altastaph [Staphylococcus aureus Immune Globulin (Human)] for immediate protection against Staph ...More

February 12, 2004

Posted in News

ANTIMICROBIAL PRODUCTS	DISINFECTION/STERILIZA...
DISPOSABLE PRODUCTS	INFECTION CONTROL
LATEX-FREE PRODUCTS	More Options...

Immune System

Video Snapshot

Galleries

ICT Poll

Most Popular Articles

Buyer's Guide

Reports

Free Email Updates

featured links

First Name	Last Name
E-Mail